Global Viral Vector Purification Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Viral Vector Purification Market Analysis

  • Healthcare
  • Feb 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

The viral vector purification market is advancing rapidly with innovative technologies enhancing purification processes. This evolution includes novel chromatography techniques, membrane-based systems, and scalable solutions for large-scale viral vector production. These advancements contribute to the efficient isolation and purification of viral vectors, crucial for gene therapy and vaccine development applications.                                

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on , By Product and Services (Products and Services), Type (Retroviral Vectors, Vaccine Virus, Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentivirus and Other), Workflow (Upstream Processing and Downstream Processing), Purification Technique (Density-Gradient Ultracentrifugation, Ultrafiltration, Precipitation, Two-Phase Extraction Systems and Chromatography), Scale of Operation (Preclinical / Clinical and Commercial), Delivery Method (In Vivo and Ex Vivo), Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease and Other), Application (Antisense And RNAi, Gene Therapy, Cell Therapy and Vaccinology), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/ Research Institutes) – Industry Trends and Forecast to 2032 .
The Global Viral Vector Purification Market size was valued at USD 813.03 USD Million in 2024.
The Global Viral Vector Purification Market is projected to grow at a CAGR of 14.2% during the forecast period of 2025 to 2032.
The major players operating in the market include Applied Biological Materials Inc. , Creative Biolabs , Bio-Rad LaboratoriesInc. , SIRION BIOTECH GmbH , Merck KGaA , FUJIFILM Diosynth Biotechnologies , Batavia Biosciences B.V. AGilent TechnologiesInc. , Addgene , IDT Biologika , ProBioGen AG , Takara Bio Inc. , Thermo Fisher Scientific Inc. , Waisman Biomanufacturing , Creative Biogene , Aldevron , uniQure N.V. , Cytiva and Sartorius BIA Separations .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..